Targeting the translation machinery in cancer

Area of Science:

• Molecular Biology
• Oncology
• Biochemistry

Background:

• Dysregulated mRNA translation is a hallmark of neoplasia.
• Oncogenes and tumor suppressors frequently impact the translation machinery.
• Aberrant translation is a common characteristic of tumor cells, irrespective of their genetic profile.

Purpose of the Study:

• To review the role of mRNA translation in cancer.
• To focus on the eukaryotic translation initiation factor 4F (eIF4F) complex.
• To provide an overview of therapeutic strategies targeting translation for cancer treatment.

Main Methods:

• Literature review of studies on mRNA translation in cancer.
• Focus on the function and regulation of the eIF4F complex.
• Analysis of preclinical and clinical data for translation-targeting agents.

Main Results:

• Aberrant translation is a widespread feature in various cancers.
• The eIF4F complex plays a critical role in cancer progression.
• Targeting protein synthesis components shows potential for novel cancer therapies.

Conclusions:

• Targeting the translation machinery represents a promising therapeutic avenue for cancer.
• Agents targeting protein synthesis can potentially overcome intra-tumor heterogeneity.
• Further clinical translation of these findings is warranted.